Trial Profile
Prospective study to investigate the endoscopic efficacy of adalimumab therapy and suitable time to switch from infliximab to adalimumab in Crohn's disease patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 21 Dec 2015 New trial record